ESMO/LinkedIn
Jan 13, 2025, 12:58
Shape the future of cancer drug development with ESMO TAT
ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“Shape the future of cancer drug development: ESMO TAT represents an excellent opportunity to stay up to date with the latest early phase trials in oncology while learning multi-stakeholder perspectives.
Discuss new data and collaborate with researchers, industry partners, investors, and regulatory bodies.
Register now and save! Early registration deadline: 15 January.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 6, 2025, 11:37
Sep 6, 2025, 10:21
Sep 6, 2025, 10:00
Sep 6, 2025, 07:12